ROSE PSARA: Open Payments
NPI 1881246833 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 43 payments from 12 companies in 2025. Trend: 2023 $1,624 · 2024 $1,361 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $278 |
| Alkermes, Inc. | 5 | $219 |
| Corium, LLC | 10 | $156 |
| Tris Pharma Inc | 1 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
Products named: Auvelity, Azstarys, LYBALVI, Dyanavel XR, REXULTI, CAPLYTA, ARISTADA, TRINTELLIX.
Industry payments across MO — which companies pay providers there.
